CNET editor Gael Fashingbauer Cooper, a journalist and pop-culture junkie, is co-author of "Whatever Happened to Pudding Pops? The Lost Toys, Tastes and Trends of the '70s and '80s," as well as "The ...

The Trump Administration last week moved to reclassify marijuana as a less dangerous drug. Is the goal to reduce America’s collective IQ? The main practical effect of the Justice Department’s ...

Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

GLP-1 insurance coverage for weight loss varies greatly by plan type. Private insurance often excludes these drugs entirely, while Medicare is opening pathways for coverage. Still, access depends on ...

If you watched the Super Bowl in 2026, you likely saw Serena Williams share her weight loss journey on GLP-1 medications in a commercial. Like millions of others around the country, if you’ve ever ...

GRAND RAPIDS, Mich. — Cardiovascular disease is the number one killer of women. And yet, women are less likely to receive bystander CPR to save their lives than men. "Bystanders are concerned about ...

Washington — President Trump's budget proposal for fiscal year 2027 asks Congress for $1.5 trillion in defense spending — a 42% increase — while cutting nondefense spending by $73 billion, or 10%. The ...

President Trump is seeking $1.5 trillion in defense spending as part of the White House’s fiscal 2027 budget request, a roughly 40 percent increase from 2026 funding levels. The proposal released ...

Indication requires concomitant reduced-calorie diet and increased physical activity for long-term weight loss and maintenance in obesity or overweight with ≥1 weight-related comorbidity. ATTAIN ...

Four new tax deductions are available on federal returns for eligible taxpayers whether they itemize deductions, such as claiming mortgage interest, or claim the standard deduction. All four big tax ...

People who order low-cost versions of the wildly popular weight-loss drugs Wegovy and Zepbound from so-called compounding pharmacies might soon see disruptions in their medication. The U.S. Food and ...